Abstract
A mutant (furA3) was isolated from the S1 wild-type strain of Nectria haematococca on the basis of its resistance to 5-fluorouracil (5FU). This mutant has greatly reduced activity of uracil phosphoribosyltransferase, a pyrimidine salvage enzyme catalyzing the synthesis of UMP from uracil. The metabolism of 5FU was examined in both strains by using 19F nuclear magnetic resonance spectroscopy. In the S1 strain, 5FU appears to be metabolized by two pathways operating simultaneously: (i) conversion to fluoronucleotides and (ii) degradation into alpha-fluoro-beta-alanine. The furA3 mutant shows metabolic changes consistent with a uracil phosphoribosyltransferase lesion, since it takes up 5FU and forms a small amount of alpha-fluoro-beta-alanine but does not synthesize fluoronucleotides. Since pigment synthesis is strongly enhanced by 5FU in the S1 wild-type strain but not in the furA3 mutant, these results support the hypothesis that 5FU stimulation of secondary metabolism in N. haematococca is not mediated by the drug itself but involves a phosphorylated anabolite.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
- Di Vito M., Podo F., Torosantucci A., Carpinelli G., Whelan W. L., Kerridge D., Cassone A. A 19F nuclear magnetic resonance study of uptake and metabolism of 5-fluorocytosine in susceptible and resistant strains of Candida albicans. Antimicrob Agents Chemother. 1986 Feb;29(2):303–308. doi: 10.1128/aac.29.2.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dreyer R., Cadman E. Use of periodate and methylamine for the quantitation of intracellular 5-fluoro-2'-deoxyuridine-5'-monophosphate by high-performance liquid chromatography. J Chromatogr. 1981 Dec 4;219(2):273–284. doi: 10.1016/s0021-9673(00)87937-6. [DOI] [PubMed] [Google Scholar]
- Galun E., Gressel J. Morphogenesis in Trichoderma: suppression of photoinduction by 5-fluorouracil. Science. 1966 Feb 11;151(3711):696–698. doi: 10.1126/science.151.3711.696. [DOI] [PubMed] [Google Scholar]
- Garrett C., Santi D. V. A rapid and sensitive high pressure liquid chromatography assay for deoxyribonucleoside triphosphates in cell extracts. Anal Biochem. 1979 Nov 1;99(2):268–273. doi: 10.1016/s0003-2697(79)80005-6. [DOI] [PubMed] [Google Scholar]
- Gochin M., James T. L., Shafer R. H. In vivo 19F-NMR of 5-fluorouracil incorporation into RNA and metabolites in Escherichia coli cells. Biochim Biophys Acta. 1984 May 22;804(1):118–124. doi: 10.1016/0167-4889(84)90105-8. [DOI] [PubMed] [Google Scholar]
- Heidelberger C., Danenberg P. V., Moran R. G. Fluorinated pyrimidines and their nucleosides. Adv Enzymol Relat Areas Mol Biol. 1983;54:58–119. [PubMed] [Google Scholar]
- Horowitz J., Kohlmeier V. Formation of active beta-galactosidase by Escherichia coli treated with 5-fluorouracil. Biochim Biophys Acta. 1967 Jun 20;142(1):208–218. doi: 10.1016/0005-2787(67)90528-x. [DOI] [PubMed] [Google Scholar]
- Jones G. E. 6-azauracil-resistant variants of cultured plant cells lack uracil phosphoribosyltransferase activity. Plant Physiol. 1984 May;75(1):161–165. doi: 10.1104/pp.75.1.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jund R., Lacroute F. Genetic and physiological aspects of resistance to 5-fluoropyrimidines in Saccharomyces cerevisiae. J Bacteriol. 1970 Jun;102(3):607–615. doi: 10.1128/jb.102.3.607-615.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Keniry M., Benz C., Shafer R. H., James T. L. Noninvasive spectroscopic analysis of fluoropyrimidine metabolism in cultured tumor cells. Cancer Res. 1986 Apr;46(4 Pt 1):1754–1758. [PubMed] [Google Scholar]
- Lindenmayer A., Schoen H. F. Selective effects of purine and pyrimidine analogues and of respiratory inhibitors on perithecial development and branching in sordaria. Plant Physiol. 1967 Aug;42(8):1059–1070. doi: 10.1104/pp.42.8.1059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Malet-Martino M. C., Faure F., Vialaneix J. P., Palevody C., Hollande E., Martino R. Noninvasive fluorine-19 NMR study of fluoropyrimidine metabolism in cell cultures of human pancreatic and colon adenocarcinoma. Cancer Chemother Pharmacol. 1986;18(1):5–10. doi: 10.1007/BF00253054. [DOI] [PubMed] [Google Scholar]
- O'Byrne-Ring N., Duke E. Biochemical and genetic basis of the response to 5-fluorouracil in Drosophila melanogaster. Biochem Genet. 1980 Aug;18(7-8):717–726. doi: 10.1007/BF00484588. [DOI] [PubMed] [Google Scholar]
- Palmer L. M., Scazzocchio C., Cove D. J. Pyrimidine biosynthesis in Aspergillus nidulans. Isolation and characterisation of mutants resistant to fluoropyrimidines. Mol Gen Genet. 1975 Sep 29;140(2):165–173. doi: 10.1007/BF00329784. [DOI] [PubMed] [Google Scholar]
- Parente A., Arking R., Kalata K. Effect of DNA inhibitors upon DNA synthesis and development of Drosophila embryos. J Exp Zool. 1980 May;212(2):195–204. doi: 10.1002/jez.1402120206. [DOI] [PubMed] [Google Scholar]
- Valeriote F., Santelli G. 5-Fluorouracil (FUra). Pharmacol Ther. 1984;24(1):107–132. doi: 10.1016/0163-7258(84)90030-5. [DOI] [PubMed] [Google Scholar]
- Vialaneix J. P., Chouini N., Malet-Martino M. C., Martino R., Michel G., Lepargneur J. P. Noninvasive and quantitative 19F nuclear magnetic resonance study of flucytosine metabolism in Candida strains. Antimicrob Agents Chemother. 1986 Nov;30(5):756–762. doi: 10.1128/aac.30.5.756. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wain W. H., Staatz W. D. Rates of synthesis of ribosomal protein and total ribonucleic acid through the cell cycle of the fission yeast Schizosaccharomyces pombe. Exp Cell Res. 1973 Oct;81(2):269–278. doi: 10.1016/0014-4827(73)90515-6. [DOI] [PubMed] [Google Scholar]
- Waldorf A. R., Polak A. Mechanisms of action of 5-fluorocytosine. Antimicrob Agents Chemother. 1983 Jan;23(1):79–85. doi: 10.1128/aac.23.1.79. [DOI] [PMC free article] [PubMed] [Google Scholar]